Dr. James Thompson

James Thompson, D.O., F.A.C.P.

Co-Director Bone Marrow Transplantation Program
Indiana Blood and Marrow Transplantation


Office Address

Indiana Blood and Marrow Transplantation
8111 South Emerson Avenue
Indianapolis, IN 46237
Office Phone 317 865.5500
Office FAX 317 782.6316

Top of the Page


Education

1969-73 United States Air Force Academy - B.S. Life Sciences - Pre-Medical
1975-79 Chicago School of Osteopathic Medicine - D. O.
1979-82 Wilford Hall USAF Medical Center - Residency Internal Medicine
1982-85 Stanford University - Fellowship Hematology / Medical Oncology
1986 Fred Hutchinson Cancer Research Center - Allogeneic Bone Marrow Transplantation

Top of the Page


Academic Appointments

1989-93 Uniformed Services University of the Health Sciences
Assistant Professor of Medicine
1990-91 University of Texas Health Sciences Center at San Antonio
Clinical Assistant Professor of Medicine
1991-93 University of Texas Health Sciences Center at San Antonio
Clinical Associate Professor of Medicine

Top of the Page


Medical Staff Appointments

1985-93 Wilford Hall USAF Medical Center - Medical Staff
1993- Methodist Hospital of Indiana, Inc - Medical Staff
1996- Community Hospitals of Indianapolis - Medical Staff
1999- St. Francis Hospital and Health Centers - Medical Staff

Top of the Page


Hospital Committees and Services

1985-87 Wilford Hall USAF Medical Center - Medical Director Special Hematology Laboratory
1987-89 Wilford Hall USAF Medical Center - Medical Director Bone Marrow Transplant Unit
1989-92 Wilford Hall USAF Medical Center - Chairman and Fellowship Director, Department of Hematology and Medical Oncology
1992-93 Wilford Hall USAF Medical Center - Director, Bone Marrow Transplant Program
1987-93 O'CHAMPUS Consultant for Allogeneic and Autologous Bone Marrow Transplantation
1989-93 Consultant to the Surgeon General of the United States Air Force for Medical Oncology
1986-93 Wilford Hall USAF Medical Center
      - Surgical Case Review, Tissue, Blood Transfusion Committee
      - Medical Ethics/Cerebral Survival Committee
1989-93 Wilford Hall USAF Medical Center - Clinical Cancer Activities Committee
1992-93 Southwest Oncology Group - Bone Marrow Transplant Committee
1993- IBMT - Co-Director Stem Cell Transplant Program
1999- St. Francis Hospital - Co-Director Stem Cell Transplant Program

Top of the Page


Honors

1987 Sigma Sigma Phi in Medical School (AOA equivalent)
1980 Most Outstanding Medical Intern, Wilford Hall USAF Medical Center
1982 Outstanding Resident Teacher, Wilford Hall USAF Medical Center
1991, 1992 Most Valued Instructor - Uniformed Services University of the Health Science Internal Medicine Preceptor
1994 Finalist, Golden Cane Award for the Most Outstanding Faculty Member, Wilford Hall Medical Center

Top of the Page


Certification

1982 Internal Medicine
1985 Medical Oncology
1986 Hematology

Top of the Page


Professional Societies

American Society of Hematology
American Society of Clinical Oncologist
American College of Physicians (Fellow)
Society of Air Force Physicians - Member, Board of Governors 1989-92
American Society for Blood and Marrow Transplantation

Top of the Page


Publications

10 most recent publications out of a total of 62

Q. Chang, S Hanks, L Akard, J Thompson, K Harvey, D English, J Jansen:Maturation of mobilized peripheral blood progenitor cells: Preclinical and Phase I clinical studies. Journal of Hematotherapy, 4: 289-297, 1995.

Jansen J, Hanks S, Akard LP, Thompson JM, Burns S, Chang Q, English D, Garrett P. Immunomagnetic CD4 + CD8 depletion for patients at high risk for severe acute GVHD. Bone Marrow Transplantation, 17: 377-382, 1996.

Harvey K, Siddiqui RA, Jansen J, Akard L, Thompson J, Cui Y, Change Q, English D. Growth- factor induction of cytosolic protein tyrosine kinase activity in human hematopoietic progenitor cells isolated by flow cytometry. British Journal of Hematology, 93: 515-526, 1996.

Akard LP, Wiemann M, Thompson JM, Swinney M, Lynn K, Hanks S, Jansen J.Impaired stem cell collection by consecutive courses of high-dose mobilizing chemotherapy using cyclophosphamide, etoposide and G-CSF. Journal of Hematotherapy, 5:271-277, 1996.

Cui Y, Harvey K, Siddiqui R, Jansen J, Akard L, Thompson J. Cytosolic inactivation of translocated neutrophil plasma membrane protein tyrosine phosphatase. Blood, 87: 341-349, 1996.

Chang Q, Harvey K, Akard L, Thompson J, Dugan M, English D, Jansen J:Differences in CD34+ cell subpopulations between human bone marrow and "mobilized" peripheral blood as determined by counterflow centrifugal elutriation. Experimental Hematology, 25:423-431, 1997.

Harvey K, Higgins N, Akard L, Chang Q, Jansen J, Thompson J, Dugan M, Rizzo MT, English D. Lineage commitment of HLA-DR/CD38-defined progenitor cell subpopulations in bone marrow and mobilized peripheral blood assessed by four-color immunofluorescence. Journal of Hematotherapy, 6:243-252, 1997.

Chang Q, Harvey K, Akard L, Thompson J, Dugan M, English D, and Jansen J: Counterflow centrifugal elutriation as a method of T cell depletion may cause loss of immature CD34+ cells. Bone Marrow Transplantation, 19:1145-1150, 1997.

Essell JH, Schroeder MT, Harman GS, Halvorson RD, Lew V, Callander N, Snyder M, Lewis SK, Allerton JP, and Thompson J. Ursodiol Prophylaxis against Hepatic Complications of Allogeneic Bone Marrow Transplantation. Annals of Internal Medicine, 128:975-981, 1998.

Jansen, J, Thompson EM, Hanks S, Greenspan AR, Thompson, JM, Dugan MJ, and Akard LP. Hematopoietic growth factor after autologous peripheral blod transplantation: comparison of G-CSF and GM-CSF. Bone Marrow Transplantation, 23:1251-1256, 1999

Top of the Page

Rev. 7/2000